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Effects of Chlorinated Drinking Water on
Human Lipid Metab-olism
by Robert G. Wones* and Charles J. Glueck*
Atherosclerosis with its complications is the most important health problem affecting American adults.
The levels of serum cholesterol, of high and low density lipoproteins, and of apolipoproteins Al, A2, and
B are major risk factors for the development of atherosclerotic lesions. Animal studies suggest that
chlorinated drinking water may elevate the serum cholesterol. Studies are too limited to confirm or refute
this effect in humans. Since millions ofhumans have and have had daily exposure to chlorinateddrinking
water, it is essential to study the effects of such exposure on human lipid metabolism. We have begun a
protocol to discover whether consuming chlorinated drinking water elevates serum cholesterol and the
other lipid components of blood known to be associated with atherosclerosis. This protocol has been
designed to improve the chance ofobserving an effect while preserving the ability to generalize the data.
Introduction
Atherosclerosis with its complications is the most im-
portant health problem affecting American adults (1).
Heart disease, most of which is caused by blockage of
the coronary arteries by atherosclerotic plaques, is the
most common cause of death in persons over 35 years
of age. Cerebrovascular disease, most of which is also
caused by atherosclerotic lesions, is among the top 10
causes of death in young and middle-aged adults and
equals cancer as the second leading cause of mortality
in the aged. These diseases and others caused by ath-
erosclerosis such asaortic aneurysmandperipheral vas-
cular insufficiency also account for much ofthe morbid-
ity and disability in our population.
The levels of cholesterol and other serum lipid com-
ponents have been shown to be major risk factors for
the development of atherosclerosis. Multiple studies
have documented the predictive value ofthe total cho-
lesterollevel (2). However, measuringthemajorhuman
lipoproteins and apolipoproteins provides even more in-
formation (3). Low-density lipoprotein cholesterol
(LDL-C) appears to be the major atherogenic compo-
nent, and an individual with high levels ofthis factor is
at high risk for cardiovascular disease. In contrast, the
level of high-density lipoprotein cholesterol (HDL-C)
correlates inversely with atherosclerotic risk. In other
words, the higher an individual's HDL-C, the lesslikely
he or she is to develop the atherosclerotic complications
detailed above. Recent work suggests that the specific
protein components of these lipoproteins, the apolipo-
proteins, may correlate even better with subsequent
cardiovascular disease. Specifically, apolipoproteins Al
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and A2, which are the major components of HDL-C,
are protective, whereas apolipoprotein B, the major
component of LDL-C, is deleterious.
Compelling evidence ofthe close association between
serumcholesterol and atherosclerosisisprovidedbythe
Lipid Research Clinic's Coronary Primary Prevention
Trial (4). In this study, lowering the serum cholesterol
by diet and cholestyramine resulted in fewer cardio-
vascular deaths than in controls among men with high
cholesterol and no known disease at the beginning of
the trial.
Many factors are known to affect human lipid metab-
olism. An individual's genetic makeup is ofprimary im-
portance, and many specific diseases have been de-
scribedinwhichsinglegeneticdefectsresultinelevated
cholesterollevelsandincreased atherosclerosisrisk. Al-
though these diseases are important, they occur rela-
tively infrequently, and the vast majority ofcardiovas-
cular illness occurs in persons without an identifiable
genetic defect. Other factors, diet in particular, play a
primary role in these persons (5). High intake of cho-
lesterol and saturated fats results in increased serum
cholesterol and LDL-C. Unsaturated fat consumption
tends to lowerthese levels. Unfortunately, the average
American diet is not ideal in this regard, although im-
provements haveoccurredinthepasttwodecades (5,6).
Many otherfactors affectthe levels ofcholesterol and
the other important lipid components (7). Obesity and
smoking are associated with lower HDL-C levels in
some persons. Regular physical exercise may increase
HDL-C levels. Premenopausal women usually have
much higher HDL-C levels than men because of their
different hormonal makeup. Many drugs, such as di-
uretics, beta blockers, niacin, and cholestyramine, are
known to affect favorably or detrimentally cholesterolWONES AND GLUECK
Table 1. Animal studies of chlorinated drinking water and
plasma cholesterol.
Species Diet Dose range, Effecta
ppm
White Normal 0,0.1,10,15,30 Increased
Carneau cholesterol at 30
pigeons ppm
Calcium-deficient 0,0.1,10,15,30 Increased
cholesterol at 10
ppm and above
Calcium-deficient, 0,0.1,10 Increased
high fat, high cholesterol at 0.1
cholesterol and 10 ppm
Rabbits Calcium-deficient 0,0.1,15 Increased
cholesterol at 15
ppm
Calcium-deficient, 0,0.1,15 Increased
high fat cholesterol at 15
ppm
Rats Unspecified 0,0.1,10 Increased
cholesterol at 10
ppm
aStatistically significant changes (p S 0.05).
and lipoprotein levels. Also, many unrelated diseases
will alterhumanlipid levels. Forexample, elevated cho-
lesterol is a well-known effect of hypothyroidism and
the nephrotic syndrome, and people with diabetes mel-
litus will often have elevated lipid levels. Thus, many
factors can influence an individual's lipid profile at any
one time.
Several studies in animals, detailed later in this pa-
per, suggest that consumption of chlorinated drinking
water increases plasma cholesterol. In view of the
known risks of elevated lipid levels, these studies are
of major concern. Exposure to chlorinated water is al-
most universal in this country as well as in many others
(8). Most public systems use chlorine as a disinfectant
and as an aid to other treatment processes. Even per-
sons who consume water from untreated wells can be
exposed to chlorinated water in swimming pools, in
canned and bottled beverages, and even from certain
foods. The exposure to chlorinated wateris soprevalent
and so continuous frominfancy to old age that any effect
it might have on human cholesterol metabolism would
have important implications for cardiovascular health.
The literature on the effects of chlorinated drinking
water onlipidmetabolism is verylimited. Theonlystud-
ies available for review are several studies of experi-
mental animals and one study in humans.
Studies of the effects of chlorinated drinking water
on cholesterol have been conducted in white Carneau
pigeons and New Zealand rabbits by Revis and col-
leagues and in rabbits and rats by Douglas and col-
leagues (9,10). The results of these studies are sum-
marized in Table 1. Chlorinated drinking water
consistently elevated these animals' plasma cholesterol
levels, although relatively high concentrations ofchlor-
ine were necessary to induce these results in those an-
imals on normal diets. However, several manipulations
ofthe diet dramatically lowered concentrations ofchlor-
ine required to produce levels more typical of human
exposure levels. Specifically, a diet low in calcium and/
or one high in cholesterol or saturated fats made the
animals sensitive tothe effectsofchlorine. Otherfactors
may also be important. Water at pH 8.5 enhanced the
observed effects, whereas water at pH 6.5 lessened
them. Dietary iodine may also play arole, although this
work is very preliminary (N. W. Revis, personal com-
munication).
Unfortunately, lipid metabolism in these animals is
very different in many respects from lipid metabolism
inhumans. Therefore, whethertheseinterestingresults
can be generalized to humans remains an unanswered
question. Limited human data showing no effect of
chlorinated drinking water on serum cholesterol are
available. However, thisresearchwas ascreeningstudy
and was not designed to investigate lipid metabolism in
detail. Therefore, its negative results may not be in-
formative about potential effects of chlorine on serum
cholesterol.
Bianchine and colleagues conducted a study ofchlor-
ine dioxide and four other drinking water disinfectants
to assess their health and metabolic effects on humans
(11,12). Chlorine was one ofthe four other disinfectants
studied and actually served as acontrolinthisresearch.
Two experiments were conducted. Phase I studied the
effects of single exposures to various concentrations of
chlorinated water, rangingfrom0.1 to 24ppm. One liter
of water was consumed on day 1 of the protocol, and
blood was collected on day 2 for many tests including
total cholesterol. On day 4 ofthe protocol, another 1-L
sample containing the next higher concentration of
chlorine was consumed, blood was collected on day 5,
and so on. In phase II of the project, the volunteers
consumed 1/2 L of 5 ppm chlorinated water daily for 12
weeks, and blood was collected weekly for cholesterol
measurements and other tests. The individuals' diets
and intake of other liquids that could contain chlorine
before and during the study were not specified.
No statistically significant effect on serum cholesterol
was found in either the phase I or the phase II studies.
Although this result is encouraging, the study was not
designed to assess critically the effects of chlorinated
drinkingwater on human lipid metabolism, and the lim-
itations ofthe project make any conclusions premature.
Specifically, lipoproteins and apolipoproteins were
not measured. Thus, important changes in HDL-C and
LDL-C could have occurred without a change in the
total cholesterol value. The many factors known to af-
fect lipid metabolism, such as diet and exercise, were
uncontrolled in this study. Any effect or lack of effect
could have been caused by alterations in these param-
eters coincidental with the project. Also, no chlorine-
free washout period was observed before initiating the
study. Since exposure to chlorine in the environment is
soprevalent, thisresearchcouldnotcomparetheresults
of consuming chlorine-treated water to those of con-
suming unchlorinated water, but rather compared the
effects of consuming a known dose of chlorine to those
of consuming another unknown dose. Also, the study
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had only 10 volunteers per group and intergroup dif-
ferences could easily have been dwarfed by intragroup
variation.
Additionally, the exposure in the phase I portion of
the project was too briefto assess the long-term effects
of chlorine. The concentration of chlorine in phase II
was adequate, but since only 1/2 L was consumed, the
total daily dose was relatively small and may have seen
insufficient to induce any effects. Thus, this project pro-
vided necessary and important baseline data on water
disinfectants, but it cannot rule out a significant effect
of chlorine on human metabolism.
In the studies by Revis and colleagues, intestinal ab-
sorption of cholesterol appeared to be increased in an-
imals given chlorinated water to drink (9). There was
no evidence that the synthesis of cholesterol in the an-
imals was increased. Preliminary work by Bercz indi-
cates that levels of thyroid hormone may be decreased
in animals exposed to chlorine-containing water disin-
fectants (P. Bercz, personal communication). Since hy-
pothyroidism is a well-known cause of elevated serum
cholesterol in humans, these data are provocative.
Methodology for Controlled Trial
Because ofthe effects that chlorine in drinking water
may have on human lipid metabolism and atheroscle-
rosis risk, the Environmental Protection Agency (EPA)
and the General Clinical Research Center (GCRC) at
the University of Cincinnati College of Medicine have
begun to study this issue. Our project is designed to
maximize the chances ofobserving an effect ofchlorine
on serum lipids while preserving the ability to gener-
alize from the data.
The General Clinical Research Center at the Univer-
sity of Cincinnati College of Medicine is a specialized
inpatient and outpatient unit funded by the Division of
Research Resources of the National Institutes of
Health. The unit is designed for and has extensive ex-
perience in careful metabolic balance studies. The staff
has much experience in this demandingkind ofresearch
and has participated in a number of careful studies in
environmental and occupational pollutants. The GCRC
has its own kitchen, its own core laboratory, its own
inpatient hospital ward, its own computer system, and
has at its disposal the full resources of the University
of Cincinnati hospital including a nationally standard-
ized lipid laboratory.
A time-line for this project is shown in Figure 1. We
will study 20 healthy men between the ages of 18 and
60 on a 15-week protocol as illustrated. Each volunteer
will serve as his own control. The specific components
of the study are listed in Table 2, and the rationale for
these components discussed below.
We chose to study healthy subjects so that the results
can be generalized to the population at large and so that
the confounding effects of other diseases can be mini-
mized. We plan to use male volunteers, since the small
monthlyfluctuations oflipids that occur duringthe men-
strual cycle could make interpretation of the results
Volunteers - 20 Healthy Males
Week: 0 3 7 11 15
i ** *
I I** ****
C12: Dist.
Water
2 PPM 5 PPM 10 PPM
*-Blood Samples for Lipids, Apolipoproteins,
and Thyroid Function Tests
FIGURE 1. Chlorinated drinkingwaterand humanlipid metabolism,
University of Cincinnati GCRC study.
more difficult. Persons on medications known to affect
lipids will be excluded. Subjects may smoke but they
will be instructed to maintain their habits before and
duringthe protocol. The amount ofregularexercise will
be recorded, and every effort will be made to keep this
constant. No alcohol intake will be allowed during the
protocol.
The diet of the volunteer will be strictly controlled,
and all meals will be eaten in the GCRC. Specifically,
the diet will be isocaloric, and weight will be measured
daily to ensure that no weight change occurs over the
15 weeks. The diet will contain 600 mg of cholesterol
daily, which is approximately twice the recommended
intake and significantly more than that consumed on
average by Americans (5). Of the calories consumed,
20% will come fromprotein, 40% fromfat, and40% from
carbohydrates. Current recommendations suggest that
no more than 30% of calories should come from fat (5).
The polyunsaturated/saturated fat ratio will be 0.4,
which is lower than that which is recommended, but
which is not atypical for American diets. The calcium
inthedietwillbecontrolledat80%ofthe Recommended
Daily Allowance (13). Thus, the diet mimics the low
calcium, high fat, and high cholesterol diet used in some
ofthe animal studies, but is not very different from the
diets of many Americans.
Subjects will receive all theirbeverages and drinking
water from the GCRC staff. They must drink at least
1.5 L/day ofthe study water. Any intake desired above
Table 2. Diet and water specifications for the GCRC study of
chlorinated drinking water and human lipid metabolism.
Specification
Diet Isocaloric
20% Protein, 40% carbohydrate, 40% fat
600 mg cholesterol daily
0.4 Polyunsaturated: saturated fat ratio
80% Minimum Daily Requirement of calcium
Water Prechlorination water distilled and carbon filtered.
Buffered at pH 8.0 by NaH2PO4
Appropriate chlorine content (chlorine gas bubbled
through distilled water alkalinized to pH 8.0 by
NaOH)
Mandatory 1.5 L of study water per day. Any
additional water will be distilled.
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that level will be distilled water. This water intake ap-
proximates the total daily fluid consumption for most
persons, and it ensures that the dose of chlorine we
deliver is adequate. The water itselfwill be distilled in
facilities in the hospital and will be circulated through
a carbon and bacteriafilter in the GCRC before use. All
the study waters during both control and study periods
will contain a constant, small amount of monobasic so-
dium phosphate and sodium hydroxide to keep the pH
of the water at 8.0. This value was chosen since the
effect of chlorine appears to be more intense at basic
pH and because U.S. drinking waters are typically al-
kaline. A concentrated chlorine solution at pH 8.0 will
be made by bubbling chlorine gas through distilled
water alkalinized by sodium hydroxide. Appropriate di-
lutions ofthis solution with addition ofthe above buffer
solution will be prepared dailyinthe GCRC kitchen and
given to the subjects in thermoses from which less than
10% ofthe chlorine has been observed to disappear over
several days. The concentrations will be 0, 2, 5, and 10
ppm. These exposures are somewhat higher than what
could be expected from most water systems but not by
more than one order of magnitude. They were chosen
because effects in animals have been seen at similar
concentrations, because Bianchine's results confirm
their safety, and because the data generated at these
levels would be most useful for regulatory purposes.
The4-weekstudyintervalforeachconcentrationshould
provide ample time to observe any effect, since all in-
terventions ofwhich we are aware have observable ef-
fects in such a period of time (14).
Each subject will have a completed history and phys-
ical examination at the beginning of the study and pe-
riodically thereafter. Blood fortotal cholesterol and tri-
glycerides, lipoproteins, and apolipoproteins Al, A2,
and B willbe collected weekly in the fasting state. Mul-
tiple samples will be collected at the end ofthe control
and study periods to allow computation of variance.
Thyroid function tests will be performed periodically,
also forreasons discussed above. Safetytests, including
methemoglobin, blood counts, and measures ofkidney,
liver, and bone function, will beperformed twice during
each interval.
We havedesigned anintensive quality assurance pro-
gram for this study that will supplement the extensive
qualitycontrolproceduresalreadyinforceintheGCRC.
The drinkingwaterwillbe tested dailyforchlorine con-
tent and pH by standard methods to ensure the dose
prescribed is the dose delivered. Dietary control pro-
cedures are and have been standard policy. The lipid
laboratory at the University ofCincinnati is nationally
standardized.
Statisticalanalysis ofthe cholesterol data willbe per-
formed using two-way analysis ofvariance by standard
methods (15).
Theproject hasbeenapprovedbytheCollege ofMed-
icine's Committee onHuman Research. Allsubjects will
give fully informed consent before admission to the
study.
Thefirstvolunteers willbegintheprotocolSeptember
4, 1985. Completion ofthisfirst phase ofthe cooperative
agreement is anticipated in late 1986.
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